OBJECTIVETo investigate the action of nitric oxide (NO) on testicular dysfunction in cirrhotic rats.

METHODSCirrhotic rats were induced by bile duct ligation (BDL). Concentration of NO in the serum and homogenates of the testicular tissue in biliary cirrhotic rats, L-NAME rats, and sham operated rats were measured by assay of nitrate reductase. Concentrations of testosterone in the serum of 3 groups were measured by radioimmunoassay. Sperm density and percent of motive sperm in the epididymis of the rats were determined.

RESULTSConcentrations of NO in the serum and homogenates of the testicular tissue of cirrhotic rats were significantly greater than those of sham operated rats (4.165 micromol/L 1.162 micromol/L, and 1.305 micromol/g 0.087 micromol/g vs 0.535 micromol/L 0.237 micromol/L and 0.720 micromol/g 0.063 micromol/g). Concentrations of testosterone in the serum, the sperm density and percent of motive sperm in the epididymis were significantly lower in cirrhotic rats than sham operated rats (0.049mug/L 0.020 microgram/L, 16.46% 4.84%, and 86.89 10(6)/ml 33.17 10(6)/ml vs 2.680 microgram/L 0.403 microgram/L, 62.45% 9.21%, and 299.43 10(6)/ml 53.85 10(6)/ml). By contrast, the administration of a low dose of L-NAME (0.5 mg/kg per day) for one week to cirrhotic rats was associated with a significant reduction in concentration of NO (1.975 micromol/L 0.406 micromol/L and 0.950 micromol/g 0.057 micromol/g) and a significant increase in concentration of testosterone in the serum, the sperm density and percent of motive sperm in the epididymis (0.993 microgram/L 0.179 microgram/L, 33.85% 4.93%, and 188.94 10(6)/ml 38.34 10(6)/ml).

CONCLUSIONSNO is associated with testicular dysfunction in cirrhosis. The testicular dysfunction induced by cirrhosis can obtain improvement by using low dose of L-NAME.

Animals ; Liver ; parasitology ; Liver Cirrhosis, Experimental ; pathology ; physiopathology ; Male ; NG-Nitroarginine Methyl Ester ; therapeutic use ; Nitric Oxide ; physiology ; Rats ; Rats, Sprague-Dawley ; Testicular Diseases ; drug therapy ; etiology ; Testis ; drug effects ; pathology ; physiopathology ; Testosterone ; blood

The technique of stem cells or hepatocytes transplantation has recently improved in order to bridge the time before whole-organ liver transplantation. In the present study, unfractionated bone marrow stem cells (BMSCs) were harvested from the tibial and femoral marrow compartments of male mice, which were cultured in Dulbecco's modified Eagle's medium (DMEM) with and without hepatocyte growth factor (HGF), and then transplanted into Schistosoma mansoni-infected female mice on their 8th week post-infection. Mice were sacrificed monthly until the third month of bone marrow transplantation, serum was collected, and albumin concentration, ALT, AST, and alkaline phosphatase (ALP) activities were assayed. On the other hand, immunohistopathological and immunohistochemical changes of granuloma size and number, collagen content, and cells expressing OV-6 were detected for identification of liver fibrosis. BMSCs were shown to differentiate into hepatocyte-like cells. Serum ALT, AST, and ALP were markedly reduced in the group of mice treated with BMSCs than in the untreated control group. Also, granuloma showed a marked decrease in size and number as compared to the BMSCs untreated group. Collagen content showed marked decrease after the third month of treatment with BMSCs. On the other hand, the expression of OV-6 increased detecting the presence of newly formed hepatocytes after BMSCs treatment. BMSCs with or without HGF infusion significantly enhanced hepatic regeneration in S. mansoni-induced fibrotic liver model and have pathologic and immunohistopathologic therapeutic effects. Also, this new therapeutic trend could generate new hepatocytes to improve the overall liver functions.
Alanine Transaminase/blood ; Alkaline Phosphatase/blood ; Animals ; Antigens, Differentiation/biosynthesis ; Aspartate Aminotransferases/blood ; Bone Marrow Cells/cytology ; *Bone Marrow Transplantation ; Cell Differentiation ; Cell- and Tissue-Based Therapy ; Cells, Cultured ; Collagen/metabolism ; Female ; Granuloma/parasitology/pathology ; Hepatocyte Growth Factor/pharmacology ; Hepatocytes/*cytology ; Liver/parasitology/pathology ; Liver Cirrhosis/parasitology/pathology/*therapy ; Male ; Mice ; Mice, Inbred BALB C ; Schistosoma mansoni/pathogenicity ; Schistosomiasis mansoni/mortality/*therapy ; *Stem Cell Transplantation ; Stem Cells/cytology